| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/08/2011 | US7902148 Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent |
| 03/08/2011 | US7902144 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 03/08/2011 | US7901716 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 03/08/2011 | US7901709 Active agent, a gel-phase lipid bilayer membrane of a phospholipid and a surface active agent contained in the bilayer membrane; increasing the percentage of active agent released at the phase transition temperature of the lipid bilayer |
| 03/08/2011 | CA2529162C Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing the same |
| 03/08/2011 | CA2498565C Composition for treating virus infection disease comprising jab1 |
| 03/08/2011 | CA2486915C Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 03/08/2011 | CA2464721C Nitrogenous (tetrahydropyridyl) (alkyl) heterocycles with tnf activity |
| 03/08/2011 | CA2460313C Bisphenylsulfanyl and sulphonate compounds and use thereof for elevating hdl cholesterol levels |
| 03/08/2011 | CA2415396C 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 03/08/2011 | CA2338504C Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 03/08/2011 | CA2137377C Retinal pigmented epithelium derived neurotrophic factor |
| 03/03/2011 | WO2011026024A2 Imidazo [4,5-d] pyridazine compounds for treating viral infections |
| 03/03/2011 | WO2011024918A1 Antiangiogenic agent and method for inhibition of angiogenesis |
| 03/03/2011 | WO2011024748A1 Modified peptide vaccine derived from influenza m2 |
| 03/03/2011 | WO2011024620A1 Antimycotic pharmaceutical composition |
| 03/03/2011 | WO2011024482A1 Method for measurement of ability of inducing antigen-specific t cells |
| 03/03/2011 | WO2011024004A1 Heterocyclic urea derivatives useful for treatment of bacterial infection |
| 03/03/2011 | WO2011023970A1 Fulvic acid compositions and their use |
| 03/03/2011 | WO2011023624A1 Bisphosphonates as inhibitors of acid sphingomyelinase |
| 03/03/2011 | WO2011023573A1 Antimicrobial amino-salicylic acid derivatives |
| 03/03/2011 | WO2011023013A1 Medicine for dissolving and eliminating wart and excrescence consisting of protein and its uses |
| 03/03/2011 | WO2011022798A1 Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same |
| 03/03/2011 | WO2010148496A8 Lipidated tumor- associated antigens and immunotherapeutic compositions |
| 03/03/2011 | WO2010129337A3 New oral formulations for tetrapyrrole derivatives |
| 03/03/2011 | WO2010129033A3 Modified antibodies for passive immunotherapy |
| 03/03/2011 | WO2010123971A3 Hydrogels for combinatorial delivery of immune-modulating biomolecules |
| 03/03/2011 | WO2010104341A9 Compositions for diagnosis of fungal infections |
| 03/03/2011 | WO2010091234A9 Methods of treating vascular lesions |
| 03/03/2011 | WO2010046931A3 Antifungal compounds containing benzothiazinone, benzoxazinone or benzoxazolinone and process thereof |
| 03/03/2011 | WO2008152447A3 Staphylococcus aureus specific anti-infectives |
| 03/03/2011 | WO2008023273A3 Method for improving pharmacokinetics |
| 03/03/2011 | US20110054347 Devices for Selective Recruitment, Isolation, Activation, and/or Elimination of Various Cell Populations |
| 03/03/2011 | US20110054237 Methods and Systems for Magnetic Focusing of Therapeutic, Diagnostic or Prophylactic Agents to Deep Targets |
| 03/03/2011 | US20110054159 Rna interference mediating small rna molecules |
| 03/03/2011 | US20110054043 Film composition |
| 03/03/2011 | US20110054039 Use of alkyl sulfates or sulfonates against propionibacterium acnes |
| 03/03/2011 | US20110054034 Methods of using carboxylic amides as antimicrobial agents |
| 03/03/2011 | US20110054028 Supplement for reducing hiv transmission and method thereof |
| 03/03/2011 | US20110053987 Pyridinium and thiazolium conjugates including polyethylene glycols and methods of using the same |
| 03/03/2011 | US20110053975 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 03/03/2011 | US20110053960 Method for treating pain syndrome and other disorders |
| 03/03/2011 | US20110053959 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 03/03/2011 | US20110053931 Quinoline compounds and methods of use |
| 03/03/2011 | US20110053930 Inhibitors of the bmp signaling pathway |
| 03/03/2011 | US20110053916 Pyrimidine compounds as tuberculosis inhibitors |
| 03/03/2011 | US20110053896 Osmolytes for the treatment of allergic or viral respiratory diseases |
| 03/03/2011 | US20110053894 Broad Spectrum Antiviral and Methods of Use |
| 03/03/2011 | US20110053893 Compounds and compositions as tlr activity modulators |
| 03/03/2011 | US20110053892 Imidazo[4,5-d]Pyridazine Compounds For Treating Viral Infections |
| 03/03/2011 | US20110053890 Synthetic analogs of bacterial quorum sensors |
| 03/03/2011 | US20110053884 Potent combinations of zidovudine and drugs that select for the k65r mutation in the hiv polymerase |
| 03/03/2011 | US20110053880 Composition for treatment of tuberculosis |
| 03/03/2011 | US20110053875 Macrolide synthesis process and solid-state forms |
| 03/03/2011 | US20110053845 Localized vaginal delivery without detrimental blood levels |
| 03/03/2011 | US20110053836 Use of defensins against tuberculosis |
| 03/03/2011 | US20110053835 Antimicrobial peptides derived from cap18 |
| 03/03/2011 | US20110053834 Novel antibiotic peptide derived from ribosomal protein l1 of helicobacter pylori and use thereof |
| 03/03/2011 | US20110053833 Synthetic peptides and their use |
| 03/03/2011 | US20110053830 Methods for treating septic shock |
| 03/03/2011 | US20110053260 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 03/03/2011 | US20110053259 Recombinant poxvirus expressing homologous genes inserted into the poxvirus genome |
| 03/03/2011 | US20110052737 Topical skin formulations comprising botanical extracts |
| 03/03/2011 | US20110052733 Herbal compositions for the treatment of mucosal lesions |
| 03/03/2011 | US20110052729 Pharmaceutical or nutraceutical composition |
| 03/03/2011 | US20110052727 Anti Influenza Nutritional Supplements |
| 03/03/2011 | US20110052725 Therapeutic agent for infectious skin and mucosal disease |
| 03/03/2011 | US20110052716 Adjuvant Comprising Aluminum, Oligonucleotide and Polycation |
| 03/03/2011 | US20110052676 Composition For Delaying Cellular Senescence |
| 03/03/2011 | US20110052664 Antimicrobial Medical Dressings and Protecting Wounds and Catheter Sites |
| 03/03/2011 | US20110052661 Pet dental hygiene product |
| 03/03/2011 | US20110052652 Solid pharmaceutical composition comprising agglomerated nanoparticles and a process for producing the same |
| 03/03/2011 | US20110052650 Porous crystalline hybrid solid for adsorbing and releasing gas of biological interest |
| 03/03/2011 | US20110052637 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as vaccines |
| 03/03/2011 | US20110052635 Live attenuated salmonella vaccine |
| 03/03/2011 | US20110052634 Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof |
| 03/03/2011 | US20110052632 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 03/03/2011 | US20110052631 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells |
| 03/03/2011 | US20110052630 Compositions and Methods Using Herpes Simplex Virus |
| 03/03/2011 | US20110052629 Methods of reducing concomitant infections in pigs with a pcv2 antigen |
| 03/03/2011 | US20110052628 Recombinant Double-Stranded RNA Phage, and Use of the Same |
| 03/03/2011 | US20110052627 Recombinant modified vaccinia virus measles vaccine |
| 03/03/2011 | US20110052626 Leporipoxvirus-derived vaccine vectors |
| 03/03/2011 | US20110052624 Type 5 And Type 8 Capsular Polysaccharides Of Overproducing S. Aureus Strains |
| 03/03/2011 | US20110052620 Hybrid polypeptides comprising gbs-80 and spb1 proteins of streptococcus |
| 03/03/2011 | US20110052619 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 03/03/2011 | US20110052618 Influenza hemagglutinin and neuraminidase variants |
| 03/03/2011 | US20110052617 Aav scleroprotein, production and use thereof |
| 03/03/2011 | US20110052610 Antibody composition exhibiting cellular cytotoxicty due to glycosylation |
| 03/03/2011 | US20110052609 Magnetic transducers |
| 03/03/2011 | US20110052606 Humanized Anti-Human NKG2A Monoclonal Antibody |
| 03/03/2011 | US20110052603 method of treatment and agents useful for same |
| 03/03/2011 | US20110052601 Compositions comprising anti-icam-1 antibodies |
| 03/03/2011 | US20110052584 Method of enhancement of cytotoxicity in antibody mediated immune responses |
| 03/03/2011 | US20110052579 Ligands of the Natural Killer (NK) Cell Surface Marker CD27 and Therapeutic Uses Thereof, |
| 03/03/2011 | US20110052571 Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies |
| 03/03/2011 | US20110052568 Tablet comprising natural allicin and method for producing the same |
| 03/03/2011 | US20110052565 Non-aggregating human vh domains |
| 03/03/2011 | US20110052562 Benzimidazoles and analogs as rho kinase inhibitors |
| 03/03/2011 | US20110052558 Materials and methods for prevention and treatment of rna viral diseases |